Literature DB >> 3954993

Resolution of highly purified toxic-shock syndrome toxin 1 into two distinct proteins by isoelectric focusing.

D A Blomster-Hautamaa, B N Kreiswirth, R P Novick, P M Schlievert.   

Abstract

Highly purified toxic-shock syndrome toxin 1 (TSST-1) was prepared by differential precipitation with ethanol and resolubilization in water followed by successive electrofocusing in pH gradients of 3-10, 6-8, and 6.5-7.5. TSST-1, thus isolated, migrated as two distinct protein bands with isoelectric points of 7.08 (TSST-1a) and 7.22 (TSST-1b). When tested by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, both toxins migrated as homogeneous bands with molecular weights of 22 000. The gel bands were visualized by silver staining. The two toxins have nearly identical amino acid compositions and are immunologically identical as shown by Ouchterlony reactivity against TSST-1 hyperimmune serum. TSST-1a and TSST-1b have the same biological activities as TSST-1: the capacity to induce fever, enhancement of host susceptibility to lethal endotoxin shock, nonspecific T lymphocyte mitogenicity, and suppression of immunoglobulin M synthesis against sheep erythrocytes. These two proteins have been isolated from several different TSS-associated Staphylococcus aureus strains. The data suggest that the differences in isoelectric point result either from the presence of a cofactor or from alternative conformations. Since only two bands appear, microheterogeneity as a result of deamination or acetylation is unlikely.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954993     DOI: 10.1021/bi00349a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Staphylococcal superantigens cause lethal pulmonary disease in rabbits.

Authors:  Kristi L Strandberg; Jessica H Rotschafer; Sara M Vetter; Rebecca A Buonpane; David M Kranz; Patrick M Schlievert
Journal:  J Infect Dis       Date:  2010-10-27       Impact factor: 5.226

3.  Ovine-associated Staphylococcus aureus protein with immunochemical similarity to toxic shock syndrome toxin 1.

Authors:  G Ho; W H Campbell; E Carlson
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

4.  Cloning and expression of streptococcal pyrogenic exotoxin A and staphylococcal toxic shock syndrome toxin-1 in Bacillus subtilis.

Authors:  B N Kreiswirth; J P Handley; P M Schlievert; R P Novick
Journal:  Mol Gen Genet       Date:  1987-06

Review 5.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

6.  Production of toxic shock syndrome-like illness in rabbits by Staphylococcus aureus D4508: association with enterotoxin A.

Authors:  B D McCollister; B N Kreiswirth; R P Novick; P M Schlievert
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

7.  Expression of staphylococcal enterotoxin C1 in Escherichia coli.

Authors:  G A Bohach; P M Schlievert
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

8.  Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1.

Authors:  W W Kum; K B Laupland; R H See; A W Chow
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

9.  Production of a toxic shock syndrome toxin variant by Staphylococcus aureus strains associated with sheep, goats, and cows.

Authors:  G Ho; W H Campbell; M S Bergdoll; E Carlson
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

10.  Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins.

Authors:  P K Lee; J R Deringer; B N Kreiswirth; R P Novick; P M Schlievert
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.